Safety and Efficacy Study of a Vaccine Against Enterotoxigenic Escherichia Coli (ETEC) to Prevent Moderate to Severe Diarrhea
Phase 2
Completed
- Conditions
- Diarrhea
- Interventions
- Biological: PlaceboBiological: ACE527
- First Posted Date
- 2010-02-02
- Last Posted Date
- 2011-03-07
- Lead Sponsor
- TD Vaccines A/S
- Target Recruit Count
- 70
- Registration Number
- NCT01060748
- Locations
- 🇺🇸
Center for Immunization Research (CIR), Baltimore, Maryland, United States
ACE527 Safety and Immunogenicity Study
Phase 1
Completed
- Conditions
- Enterotoxigenic E. Coli (ETEC) Infection
- Interventions
- Biological: ACE527 vaccineBiological: Placebo vaccine
- First Posted Date
- 2009-05-14
- Last Posted Date
- 2010-01-29
- Lead Sponsor
- TD Vaccines A/S
- Target Recruit Count
- 36
- Registration Number
- NCT00901654
- Locations
- 🇺🇸
Center for Immunization Research CIR, Baltimore, Maryland, United States
ACE393-103 Vaccination Challenge Study
Phase 2
- Conditions
- Campylobacter Infection
- Interventions
- Biological: ACE393Biological: Placebo vaccine
- First Posted Date
- 2009-03-11
- Last Posted Date
- 2009-03-11
- Lead Sponsor
- TD Vaccines A/S
- Target Recruit Count
- 72
- Registration Number
- NCT00859716
- Locations
- 🇺🇸
Shin Nippon Biomedical Laboratories, Baltimore, Maryland, United States
© Copyright 2025. All Rights Reserved by MedPath